KO2 Stock Overview Provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Clariane Historical stock prices Current Share Price €1.89 52 Week High €4.92 52 Week Low €1.38 Beta 0.96 1 Month Change 4.02% 3 Month Change 8.56% 1 Year Change -22.67% 3 Year Change -93.18% 5 Year Change -95.47% Change since IPO -95.03%
Recent News & Updates
Clariane SE, Annual General Meeting, May 14, 2025 Oct 25 Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025
Clariane Group Announces Management Changes Sep 17
Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026 Aug 06
Now 20% undervalued Jul 10
Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI). Jun 27 See more updates
Clariane SE, Annual General Meeting, May 14, 2025 Oct 25 Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025
Clariane Group Announces Management Changes Sep 17
Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026 Aug 06
Now 20% undervalued Jul 10
Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI). Jun 27
New minor risk - Shareholder dilution Jun 20 Clariane SE has filed a Follow-on Equity Offering in the amount of €237.083186 million. Jun 15
Clariane SE Appoints Sylvia Metayer as Non-Executive Director Jun 13
Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France Apr 06
Full year 2023 earnings released Mar 01 Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million. Feb 29
Investor sentiment improves as stock rises 22% Feb 29
Investor sentiment deteriorates as stock falls 18% Feb 14
Investor sentiment improves as stock rises 15% Jan 30 Clariane SE to Report First Half, 2024 Results on Jul 30, 2024
Investor sentiment deteriorates as stock falls 23% Nov 18
Investor sentiment deteriorates as stock falls 36% Oct 26
Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024 Oct 25
Investor sentiment deteriorates as stock falls 15% Sep 28
Now 20% undervalued after recent price drop Sep 26
Investor sentiment deteriorates as stock falls 16% Aug 18
First half 2023 earnings released Jul 28
Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023 Jul 12
Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023 Jul 11
Upcoming dividend of €0.25 per share at 3.3% yield Jun 14
Now 21% undervalued after recent price drop Apr 20
Investor sentiment deteriorates as stock falls 21% Feb 28
Full year 2022 earnings released Feb 22
Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others. Jan 13 Korian to Report First Half, 2023 Results on Jul 27, 2023
Investor sentiment deteriorated over the past week Oct 29
First half 2022 earnings released Jul 30
Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee Jun 23
Upcoming dividend of €0.35 per share Jun 21
Investor sentiment deteriorated over the past week Jun 11
High number of new directors Apr 27
Korian Proposes Dividend Apr 26
Full year 2021 earnings: Revenues in line with analyst expectations Feb 25
Investor sentiment deteriorated over the past week Feb 10
Investor sentiment deteriorated over the past week Jan 25
Icade Santé SAS completed the acquisition of 2 nursing homes in Le Teilleul and Notre-Dame-de-Sanilhac from Korian (ENXTPA:KORI) for €13 million. Dec 18
Korian Provides Sales Guidance for the Year 2022 Sep 08
First half 2021 earnings released: EPS €0.31 (vs €0.13 in 1H 2020) Aug 02
Korian (ENXTPA : KORI) acquired a 90% stake in Santa Croce s.r.l. Jul 02
Korian in Exclusive Talks to Acquire Osny Psychotherapy Centre in Val d’Oise Jun 26
Icade Santé SAS acquired One Post-Acute Care Facility and Two Nursing Homes from Korian (ENXTPA:KORI). Jun 25
Korian (ENXTPA:KORI) completed the acquisition of ITA Mental Health from Magnum Capital Industrial Partners. Jun 02
Korian Approves Dividend, Payable on July 1, 2021 Jun 01
Upcoming dividend of €0.30 per share May 28
Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022 Apr 20
Korian (ENXTPA:KORI) signed an agreement to acquire ITA Mental Health from Magnum Capital Industrial Partners. Mar 18
Full year 2020 earnings released Feb 26
Revenue beats expectations Feb 26 Korian (ENXTPA:KORI) acquired unknown minority stake in Viva Son Group.
New 90-day high: €32.34 Jan 06
Korian Demonstrates the Relevance of its Asset Smart Strategy through a Partnership with BNP Paribas Cardif and EDF Invest Jan 01
Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million. Dec 23
New 90-day high: €30.78 Dec 20
Korian (ENXTPA:KORI) completed the acquisition of Inicea Groupe from Antin Infrastructure Partners S.A.S. Dec 18
Korian Signs Development Partnership with Aedifica in the Netherlands Dec 11
Korian has completed a Follow-on Equity Offering in the amount of €400.250658 million. Oct 30
Korian to Report First Half, 2021 Results on Jul 29, 2021 Oct 28
New 90-day low: €26.58 Oct 24
Korian to Report Fiscal Year 2020 Results on Feb 24, 2021 Oct 19
Korian (ENXTPA:KORI) reached a non binding deal to acquire Inicea Groupe for €360 million. Oct 03
New 90-day low: €27.38 Oct 02
Korian Announces Executive Changes Oct 02
Korian (ENXTPA:KORI) entered into an agreement to acquire Five Facilities near Amsterdam from Ontzorgd Wonen Groep B.V. Sep 24
New 90-day low - €31.54 Sep 16 Korian (ENXTPA:KORI) acquired Santa Marinella. Shareholder Returns KO2 DE Healthcare DE Market 7D 2.7% -0.2% -0.3% 1Y -22.7% 16.5% 7.0%
See full shareholder returns
Return vs Market: KO2 underperformed the German Market which returned 6.8% over the past year.
Price Volatility Is KO2's price volatile compared to industry and market? KO2 volatility KO2 Average Weekly Movement 9.4% Healthcare Industry Average Movement 4.8% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: KO2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: KO2's weekly volatility has decreased from 15% to 9% over the past year, but is still higher than 75% of German stocks.
About the Company Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Show more Clariane SE Fundamentals Summary How do Clariane's earnings and revenue compare to its market cap? KO2 fundamental statistics Market cap €662.04m Earnings (TTM ) -€128.93m Revenue (TTM ) €5.17b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) KO2 income statement (TTM ) Revenue €5.17b Cost of Revenue €3.50b Gross Profit €1.67b Other Expenses €1.80b Earnings -€128.93m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 24, 2025
Earnings per share (EPS) -0.36 Gross Margin 32.25% Net Profit Margin -2.49% Debt/Equity Ratio 111.1%
How did KO2 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/26 09:33 End of Day Share Price 2024/12/23 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Clariane SE is covered by 22 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Armelle Moulin AlphaValue Fraser Donlon Berenberg Laurent Gelebart BNP Paribas Exane
Show 19 more analysts 
